echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Goliath has submitted to the State Drug Administration an application for the listing of the original oral hepatitis C cure program

    Goliath has submitted to the State Drug Administration an application for the listing of the original oral hepatitis C cure program

    • Last Update: 2020-06-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    recently, Goli announced that theCompany's(to the StateMedicines(the Supervisory Authority submitted China's first original research full oral hepatitis C treatment program to the market application, is expected to be available within 5 working days of feedback.)the program consists of Ravidasvir (Ravidasvir, RDV, ASC16) united with the Gonowei ® (Danorivir, Danoprevir, DNV) with a 12-week cure rate of 99%Ravidawe is the second anti-hepatitis Cnew drugdeveloped independently by Golii (supported by the 13th Five-Year National Science and Technology Major Special "Major New Drug Creation" project, and its clinicaltest(application was also included in the priority review process by the State Drug Administration)about the New Generation of Trans-Genotype Direct Anti-CVIRUSDrugdeveloped by The Unda
    we for NS5A Targets (combined with goliath's first innovative anti-Chepatitis ®, which was approved in early June, to form China's first total oral interferon-free hepatitis C treatment (RDV/DNV treatment regimen)the results of phase II/III clinical trials completed in Chinese mainland showed that after 12 weeks of treatment, the RDV/DNV treatment was 99% in patients with genotype 1 non-cirrhosis (SVR12) and 100% SVR12 was achieved in patients with NS5A drug-resistant mutations at baseline
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.